This site is intended for Healthcare professionals only.
×

Caplin steriles signs license, supply agreement with Baxter for injectable portfolio


Caplin steriles signs license, supply agreement with Baxter for injectable portfolio

Chennai: Pharma Major, Caplin Point Laboratories said that its wholly owned subsidiary Caplin Steriles Limited has entered into a license and supply agreement with Baxter Healthcare Corporation for five generic injectable ANDAs.

Read Also: USFDA completes inspection at Caplin Point Lab’s sterile injectable facility in Tamil Nadu

Commenting on the transaction, Mr C.C.Paarthipan, Chairman, Caplin Point Laboratories Limited, said ”We are glad to enhance our partnership with Baxter with this agreement. All these ANDAs have been developed in-house, and we’re keen to license them to Baxter, who have an excellent sales and marketing infrastructure in the US for commercialization of these products.”

Specific terms of the agreement were not disclosed.

Read Also: Baxter gets USFDA nod to Cardiovascular Medicine Eptifibatide

The following two tabs change content below.
Garima

Garima

Garima Joined Medical Dialogues as Desk Editor for Medical Dialogues in the year 2017. She covers all the Healthcare news in different categories. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751


Source: self
0 comment(s) on Caplin steriles signs license, supply agreement with Baxter for injectable portfolio

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted